Efficacy of Fractional CO2 Laser as a Mono- or Adjuvant Therapy for Alopecia Areata
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
Alopecia areata is a non-scarring hair loss disorder that affects both sexes equally.
Incidence of the disease varies for different populations and in different studies, with
global incidence ranging from 0.57% to 3.8%.
Etiology of alopecia areata is not completely understood, and the majority of evidence
suggests that genetically predisposed individuals, when exposed to an unknown trigger,
develop a predominantly autoimmune reaction, leading to acute hair loss. Environmental
triggers, including viral or bacterial infections, along with autoimmune disorders, seem to
play a major role in the development of alopecia areata.